臨床牙周病學：藥物性牙齦增生的治療專輯

目錄Contents

經典文獻 Classic Literatures

從藥物性牙齦增生患者三維坐標數據分析牙齦形態(tài)

的改變……………………………………………… 1

Analysis of changes in gingival contour from threedimensional

co-ordinate data in subjects with drug-induced

gingival overgrowth

Thomason JM, Ellis JS, Jovanovski V, Corson M, Lynch E,

Seymour RA

欒慶先 審 張井然 譯

苯妥英誘導的牙齦增生的影響因素………………… 6

Factors influencing phenytoin-induced gingival

enlargement

Majola MP, McFadyen ML, Connolly C, Nair YP, Govender M

章錦才 審 董瀟瀟 譯

藥物性牙齦增生的風險因素……………………… 13

Risk factors for drug-induced gingival overgrowth

Seymour RA, Ellis JS, Thomason JM

章錦才 審 萬鵬 譯

牙周疾病患者使用鈣離子通道拮抗劑引起牙齦增生

的處理、處方用藥、治療反應以及額外花費…… 17

Management of periodontal disease in patients using

calcium channel blockers – gingival overgrowth, prescribed

medications, treatment responses and added treatment costs

Fardal Ø, Lygre H

欒慶先 審 曾佳駿 譯

牙周治療對于環(huán)孢素A誘導的牙齦增生嚴重程度的

有效性………………………………………………… 22

Effectiveness of periodontal therapy on the severity of

cyclosporin A-induced gingival overgrowth

Aimetti M, Romano F, Debernardi C

章錦才 審 董瀟瀟 譯

鈣離子通道拮抗劑與牙齦增生的相互關系………… 27

Association between calcium channel blockers and gingival

hyperplasia

Kaur G, Verhamme KMC, Dieleman JP, Vanrolleghem A, van

Soest EM, Stricker BHCh, Sturkenboom MCJM

欒慶先 審 王延峰 譯

摘要 Abstracts

接受硝苯地平和地爾硫治療的患者在對因牙周治

療后牙齦和牙周情況的評估*… …………………… 32

Evaluation of gingival and periodontal conditions

following causal periodontal treatment in patients treated

with nifedipine and diltiazem*

BuHon P. Machuca G. Martinez-SahuquiUo A. Rios JV. Velasco E.

Rojas J. LacaJle JR

章錦才 審 董瀟瀟 譯

3種不同手術方法治療藥物性牙齦增生的療效觀察… 32

The efficacy of three different surgical techniques in the

management of drug-induced gingival overgrowth

Mavrogiannis M, Ellis JS, Seymour RA, Thomason JM

章錦才 審 董瀟瀟 譯

各種藥物對接受多種藥物治療的成年和少年腎移植

患者牙齦增生的分別影響………………………… 33

Contribution of individual drugs to gingival overgrowth

in adult and juvenile renal transplant patients treated with

multiple therapy

Wilson RF, Morel A, Smith D, Koffman CG, Ogg CS, Rigden SPA,

Ashley FP

章錦才 審 董瀟瀟 譯

接受地爾硫或維拉帕米治療患者的牙齦增生患病

率和風險…………………………………………… 33

Prevalence and risk of gingival overgrowth in patients

treated with diltiazem or verapamil

Miranda J, Brunet L, Roset P, Berini L, FarréM, Mendieta C

章錦才 審 董瀟瀟 譯

硝苯地平引起牙齦增生的發(fā)生率和嚴重程度……… 34

The incidence and severity of nifedipine-induced gingival

overgrowth

Barclay S, Thomason JM, Idle JR and Seymour RA

欒慶先 審 李雪 譯

評估環(huán)孢素A引起牙齦增生的住院患者中HLA決定

簇的分布頻率……………………………………… 34

Evaluation of the frequency of HLA determinants in patients

with gingival overgrowth induced by cyclosporine-A

Ceheci I, Kamarci A, Firatli E, Aygun S, Tanyeri H, Aydin AE,

Çarin M. Güç U, Tuncer Ö

欒慶先 審 李雪 譯

影響器官移植患者牙齦增生程度的危險因素評估

HLA表型的作用……………………………………… 35

Determinants of gingival overgrowth severity in organ

transplant patients An examination of the role of HLA

phenotype

Thomason JM. Seymour R.4. Ellis JS. Kelly PJ. Parry G. Dark J.

Wilkin.son R, Ilde JR

欒慶先 審 李雪 譯

移植前牙齦增生可預測環(huán)孢素引起腎移植患者牙齦

嚴重增生……………………………………………… 35

Pre-transplant gingival hyperplasia predicts severe

cyclosporin-induced gingival overgrowth in renal

transplant patients

Varga E. Lennon MA, Mair LH

欒慶先 審 李雪 譯

藥物性牙齦增生：一項對法國藥物警戒數據庫的研究… 36

Drug-induced gingival overgrowth: a study in the French

Pharmacovigilance Database

Bondon-Guitton E, Bagheri H, Montastruc J-L

章錦才 審 萬鵬 譯

腎移植術后服用環(huán)孢素A的患者的IL-1A基因多態(tài)性與

牙齦增生的關系……………………………………… 36

Relationship between IL-1A polymorphisms and gingival

overgrowth in renal transplant recipients receiving Cyclosporin A

Bostanci N, Ilgenli T, Pirhan DC, Clarke FM, Marcenes W, Atilla

G, Hughes FJ, McKay IJ

章錦才 審 萬鵬 譯

葉酸對苯妥英性牙齦增生的作用………………… 37

Effect of folate on phenytoin hyperplasia

Drew HJ. Vogel RI. Mohfsky W. Baker H and Frank O

章錦才 審 萬鵬 譯

器官移植后應用免疫抑制劑他克莫司的患者牙齦增

生的患病率…………………………………………… 37

Prevalence of gingival overgrowth in transplant patients

immunosuppressed with tacrolimus

Ellis JS, Seymour RA, Taylor JJ, Thomason JM

章錦才 審 萬鵬 譯